The ketogenic diet is increasing in popularity worldwide, as evidenced by this symposium. More child neurologists are prescribing it in more countries. However, the diet is still underutilized, only occasionally rising to the level of "last resort" among treatment options. Though much work remains to be done to make its use more widespread, recent developments provide reason to believe the future is promising.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0883073813487602 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Proposal: Bold New Indications for Transcatheter Pulmonary Flow Restrictors.
Pediatr Cardiol
January 2025
Pediatric Heart Center, Johann-Wolfgang-Goethe University Clinic, Theodor-Storm-Kai 7, 60596, Frankfurt, Germany.
This proposal presents a proof of concept for the use of pulmonary flow restrictors (PFRs) based on MVP™-devices, drawing from clinical experience, and explores their potential role in the management of newborns with hypoplastic left heart syndrome (HLHS), other complex left heart lesions, and infants with end-stage dilated cardiomyopathy (DCM). At this early stage of age, manually adjusted PFRs can be tailored to patient's size and hemodynamic needs. Although currently used off-label, PFRs have substantial potential to improve outcomes in these vulnerable patient populations.
View Article and Find Full Text PDFEmerging medications and pharmacological treatment approaches for substance use disorders.
Pharmacol Biochem Behav
December 2024
Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA; Rutgers Addiction Research Center, Brain Health Institute, Rutgers Health, Piscataway, NJ, USA; School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia; Brain and Mind Centre, The University of Sydney, Sydney, NSW, Australia. Electronic address:
Medications to treat substance use disorders remain suboptimal or, in the case of stimulants and cannabis, non-existent. Many factors have contributed to this paucity, including the biological complexity of addiction, regulatory challenges, and a historical lack of enthusiasm among pharmaceutical companies to commit resources to this disease space. Despite these headwinds, the recent opioid crisis has highlighted the devastating consequences of SUDs for both individuals and society, stimulating urgent efforts to identify novel treatment approaches.
View Article and Find Full Text PDFIndividual differences in online research: Comparing lab-based and online administration of a psycholinguistic battery of linguistic and domain-general skills.
Behav Res Methods
December 2024
Max Planck Institute for Psycholinguistics, Wundtlaan 1, 6525 XD, Nijmegen, The Netherlands.
Experimental psychologists and psycholinguists increasingly turn to online research for data collection due to the ease of sampling many diverse participants in parallel. Online research has shown promising validity and consistency, but is it suitable for all paradigms? Specifically, is it reliable enough for individual differences research? The current paper reports performance on 15 tasks from a psycholinguistic individual differences battery, including timed and untimed assessments of linguistic abilities, as well as domain-general skills. From a demographically homogenous sample of young Dutch people, 149 participants participated in the lab study, and 515 participated online.
View Article and Find Full Text PDFAdvancing diabetic wound care: The role of copper-containing hydrogels.
Heliyon
October 2024
Department of Tissue Engineering, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Diabetic wounds pose a significant challenge in healthcare due to their complex nature and the difficulties they present in treatment and healing. Impaired healing processes in individuals with diabetes can lead to complications and prolonged recovery times. However, recent advancements in wound healing provide reasons for optimism.
View Article and Find Full Text PDFPreferences of melanoma patients to accept adjuvant therapy and toxicity - a qualitative substudy of the GerMelaTox-A project.
J Cancer Res Clin Oncol
December 2024
Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.
Purpose: Targeted treatment and immunotherapy, both adjuvant treatment options, come with a certain toxicity and can cause severe side effects. To date, data about the underlying reasons for patients to accept or reject specific types of adjuvant therapy is scarce. Therefore, this study investigates the motives of melanoma patients for tolerating or rejecting adjuvant therapy and its side effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!